Dara Wright Bio Rad Laboratories, Inc. (BIO) insider trading activity

Dara Wright is EVP, President, CDG of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 1,827 shares of BIO, which is worth approximately $608,226. The most recent transaction as insider was on Dec 16, 2023, when has been sold 174 shares (Bio-Rad A Common Stock) at a price of $306.12 per share, resulting in proceeds of $53,264. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.83K

0% 3M change

31.85% 12M change

Total Value Held $608,226

DARA WRIGHT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2023	SELL Payment of exercise price or tax liability	$53,264 $306.12 p/Share	174 Reduced 8.7%	1,827 Bio-Rad A Common Stock
Dec 16 2023	BUY Exercise of conversion of derivative security	-	502 Added 20.06%	2,001 Bio-Rad A Common Stock
Dec 12 2023	SELL Open market or private sale	$358,992 $299.16 p/Share	1,200 Reduced 44.46%	1,499 Bio-Rad A Common Stock
Sep 02 2023	SELL Payment of exercise price or tax liability	$59,190 $394.6 p/Share	150 Reduced 5.3%	2,681 Bio-Rad A Common Stock
Sep 02 2023	BUY Exercise of conversion of derivative security	-	433 Added 13.27%	2,831 Bio-Rad A Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$126,666 $394.6 p/Share	321 Reduced 11.81%	2,398 Bio-Rad A Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	925 Added 26.7%	2,539 Bio-Rad A Common Stock
Dec 16 2022	SELL Payment of exercise price or tax liability	$92,203 $407.98 p/Share	226 Reduced 11.37%	1,761 Bio-Rad A Common Stock
Dec 16 2022	BUY Exercise of conversion of derivative security	-	502 Added 20.17%	1,987 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$71,748 $478.32 p/Share	150 Reduced 9.32%	1,459 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	433 Added 21.2%	1,609 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$68,561 $486.25 p/Share	141 Reduced 10.71%	1,176 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	405 Added 23.52%	1,317 Bio-Rad A Common Stock
Dec 16 2021	SELL Payment of exercise price or tax liability	$162,289 $734.34 p/Share	221 Reduced 19.86%	892 Bio-Rad A Common Stock
Dec 16 2021	BUY Exercise of conversion of derivative security	-	502 Added 31.08%	1,113 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$123,866 $825.77 p/Share	150 Reduced 19.71%	611 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	-	433 Added 36.26%	761 Bio-Rad A Common Stock
Dec 16 2020	SELL Payment of exercise price or tax liability	$100,349 $576.72 p/Share	174 Reduced 34.66%	328 Bio-Rad A Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	-	502 Added 50.0%	502 Bio-Rad A Common Stock

Dara Wright

EVP, President, CDG

Hercules, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account